Comparison of Dual-Immunosuppressive Therapy and a Voclosporin-Based, Triple-Immunosuppressive Regimen for Lupus Nephritis: A Propensity Analysis of ALMS and AURORA 1 (KIDNEY WEEK 2023) - Oct 15, 2023 - Abstract #SA-PO877; Pres time: Nov 4, 2023; 10:00 AM - 12:00 PM; Location: Exhibit Hall, Pennsylvania Convention Center; "The above findings affirm the KDIGO 2023 recommendation that a voclosporin-based, triple-immunotherapy regimen should be considered as initial therapy in active LN."
CNS Disorders • Gastrointestinal Disorder • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Mental Retardation • Nephrology • Psychiatry
|
|
Ernie Yap1; Maria Dall'Era2; Matt Truman1; Lucy S. Hodge1; Neil Solomons3
|